5-(Chloromethyl)-3-methyl-1,2,4-oxadiazole → 5-tert-Butyl-3-(3-methyl-[1,2,4]oxadiazol-5-ylmethyl)-7-(2-oxa-6-aza-spiro[3.3]hept-6-yl)-3H-[1,2,3]triazolo[4,5-d]pyrimidine

HRID 2173630Notes

Reaction equation

HRID 2173630 reaction equation
C(C1N=C(N2CCC(F)(F)C2)C2N=NN(CC)C=2N=1)(C)(C)C.[C:23]([C:27]1[N:28]=[C:29]([N:36]2[CH2:42][C:38]3([CH2:41][O:40][CH2:39]3)[CH2:37]2)[C:30]2[N:35]=[N:34][NH:33][C:31]=2[N:32]=1)([CH3:26])([CH3:25])[CH3:24].Cl[CH2:44][C:45]1[O:49][N:48]=[C:47]([CH3:50])[N:46]=1>>[C:23]([C:27]1[N:28]=[C:29]([N:36]2[CH2:37][C:38]3([CH2:39][O:40][CH2:41]3)[CH2:42]2)[C:30]2[N:35]=[N:34][N:33]([CH2:44][C:45]3[O:49][N:48]=[C:47]([CH3:50])[N:46]=3)[C:31]=2[N:32]=1)([CH3:26])([CH3:24])[CH3:25]

Participants

4

Procedure

In analogy to the procedure described for the synthesis of 5-tert-butyl-7-(3,3-difluoropyrrolidin-1-yl)-3-ethyl-3H-[1,2,3]triazolo[4,5-d]pyrimidine (example 61), the title compound was prepared from 5-tert-Butyl-7-(2-oxa-6-aza-spiro[3.3]hept-6-yl)-3H-[1,2,3]triazolo[4,5-d]pyrimidine and 5-(chloromethyl)-3-methyl-1,2,4-oxadiazole and isolated as light-red solid. MS(m/e): 371.2 (MH+).

Workup

  1. customisolated as light-red solid

Sources & evidence

ORD record
ord-0c2ffe200ef743f3a74b53ec4f719b64
Source dataset
uspto-grants-2015_06
Patent number
US09056866B2

Reaction notes

Loading…